Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy.

MLA

Qiao, Qi, et al. “Detection and Functional Characterization of a Novel MEF2A Variation Responsible for Familial Dilated Cardiomyopathy.” Clinical Chemistry & Laboratory Medicine, vol. 59, no. 5, May 2021, pp. 955–63. EBSCOhost, https://doi.org/10.1515/cclm-2020-1318.

APA

Qiao, Q., Zhao, C.-M., Yang, C.-X., Gu, J.-N., Guo, Y.-H., Zhang, M., Li, R.-G., Qiu, X.-B., Xu, Y.-J., & Yang, Y.-Q. (2021). Detection and functional characterization of a novel MEF2A variation responsible for familial dilated cardiomyopathy. Clinical Chemistry & Laboratory Medicine, 59(5), 955–963. https://doi.org/10.1515/cclm-2020-1318

Chicago

Qiao, Qi, Cui-Mei Zhao, Chen-Xi Yang, Jia-Ning Gu, Yu-Han Guo, Min Zhang, Ruo-Gu Li, Xing-Biao Qiu, Ying-Jia Xu, and Yi-Qing Yang. 2021. “Detection and Functional Characterization of a Novel MEF2A Variation Responsible for Familial Dilated Cardiomyopathy.” Clinical Chemistry & Laboratory Medicine 59 (5): 955–63. doi:10.1515/cclm-2020-1318.